Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence
Candida albicans is an opportunistic fungal pathogen responsible for superficial and life-threatening infections in humans. During mucosal infection, C. albicans undergoes a morphological transition from yeast to invasive filamentous hyphae that secrete candidalysin, a 31-amino-acid peptide toxin re...
Saved in:
Published in | mBio Vol. 9; no. 1 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
23.01.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 2161-2129 2150-7511 2150-7511 |
DOI | 10.1128/mBio.02178-17 |
Cover
Summary: | Candida albicans
is an opportunistic fungal pathogen responsible for superficial and life-threatening infections in humans. During mucosal infection,
C. albicans
undergoes a morphological transition from yeast to invasive filamentous hyphae that secrete candidalysin, a 31-amino-acid peptide toxin required for virulence. Candidalysin damages epithelial cell plasma membranes and stimulates the activating protein 1 (AP-1) transcription factor c-Fos (via p38–mitogen-activated protein kinase [MAPK]), and the MAPK phosphatase MKP1 (via extracellular signal-regulated kinases 1 and 2 [ERK1/2]–MAPK), which trigger and regulate proinflammatory cytokine responses, respectively. The candidalysin toxin resides as a discrete cryptic sequence within a larger 271-amino-acid parental preproprotein, Ece1p. Here, we demonstrate that kexin-like proteinases, but not secreted aspartyl proteinases, initiate a two-step posttranslational processing of Ece1p to produce candidalysin. Kex2p-mediated proteolysis of Ece1p after Arg61 and Arg93, but not after other processing sites within Ece1p, is required to generate immature candidalysin from Ece1p, followed by Kex1p-mediated removal of a carboxyl arginine residue to generate mature candidalysin.
C. albicans
strains harboring mutations of Arg61 and/or Arg93 did not secrete candidalysin, were unable to induce epithelial damage and inflammatory responses
in vitro
, and showed attenuated virulence
in vivo
in a murine model of oropharyngeal candidiasis. These observations identify enzymatic processing of
C. albicans
Ece1p by kexin-like proteinases as crucial steps required for candidalysin production and fungal pathogenicity.
IMPORTANCE
Candida albicans
is an opportunistic fungal pathogen that causes mucosal infection in millions of individuals worldwide. Successful infection requires the secretion of candidalysin, the first cytolytic peptide toxin identified in any human fungal pathogen. Candidalysin is derived from its parent protein Ece1p. Here, we identify two key amino acids within Ece1p vital for processing and production of candidalysin. Mutations of these residues render
C. albicans
incapable of causing epithelial damage and markedly reduce mucosal infection
in vivo
. Importantly, candidalysin production requires two individual enzymatic events. The first involves processing of Ece1p by Kex2p, yielding immature candidalysin, which is then further processed by Kex1p to produce the mature toxin. These observations identify important steps for
C. albicans
pathogenicity at mucosal surfaces.
Candida albicans
is an opportunistic fungal pathogen that causes mucosal infection in millions of individuals worldwide. Successful infection requires the secretion of candidalysin, the first cytolytic peptide toxin identified in any human fungal pathogen. Candidalysin is derived from its parent protein Ece1p. Here, we identify two key amino acids within Ece1p vital for processing and production of candidalysin. Mutations of these residues render
C. albicans
incapable of causing epithelial damage and markedly reduce mucosal infection
in vivo
. Importantly, candidalysin production requires two individual enzymatic events. The first involves processing of Ece1p by Kex2p, yielding immature candidalysin, which is then further processed by Kex1p to produce the mature toxin. These observations identify important steps for
C. albicans
pathogenicity at mucosal surfaces. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article is a direct contribution from a Fellow of the American Academy of Microbiology. Solicited external reviewers: Richard Bennett, Brown University; Robin May, University of Birmingham. J.P.R. and S.M. contributed equally to this work. Present address: Giulia Carrano, Department of Nursing I, Faculty of Medicine and Nursing, University of the Basque Country, Leioa, Spain. |
ISSN: | 2161-2129 2150-7511 2150-7511 |
DOI: | 10.1128/mBio.02178-17 |